Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Can Fite Biopharma Ltd ADR stock

Learn how to easily invest in Can Fite Biopharma Ltd ADR stock.

Can Fite Biopharma Ltd ADR is a biotechnology business based in the US. Can Fite Biopharma Ltd ADR shares (CANF) are listed on the NYSE MKT and all prices are listed in US Dollars. Can Fite Biopharma Ltd ADR employs 8 staff and has a trailing 12-month revenue of around $864,000.

How to buy shares in Can Fite Biopharma Ltd ADR

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CANF – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Can Fite Biopharma Ltd ADR stock price (NYSE MKT: CANF)

Use our graph to track the performance of CANF stocks over time.

Can Fite Biopharma Ltd ADR shares at a glance

Information last updated 2022-09-27.
Latest market close$0.76
52-week range$0.74 - $2.60
50-day moving average $0.87
200-day moving average $1.02
Wall St. target price$6.08
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.75

Buy Can Fite Biopharma Ltd ADR shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Can Fite Biopharma Ltd ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Can Fite Biopharma Ltd ADR price performance over time

Historical closes compared with the close of $0.76 from 2022-09-26

1 week (2022-09-20) -7.32%
1 month (2022-08-26) -20.83%
3 months (2022-06-28) -13.64%
6 months (2022-03-28) -33.91%
1 year (2021-09-28) -55.03%
2 years (2020-09-28) -55.81%
3 years (2019-09-27) 2.11
5 years (2017-09-27) 1.7215

Can Fite Biopharma Ltd ADR financials

Revenue TTM $864,000
Gross profit TTM $853,000
Return on assets TTM -61.3%
Return on equity TTM -175.39%
Profit margin 0%
Book value $0.36
Market capitalisation $20.7 million

TTM: trailing 12 months

Can Fite Biopharma Ltd ADR share dividends

We're not expecting Can Fite Biopharma Ltd ADR to pay a dividend over the next 12 months.

Have Can Fite Biopharma Ltd ADR's shares ever split?

Can Fite Biopharma Ltd ADR's shares were split on a 1:15 basis on 9 May 2019. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Can Fite Biopharma Ltd ADR shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Can Fite Biopharma Ltd ADR shares which in turn could have impacted Can Fite Biopharma Ltd ADR's share price.

Can Fite Biopharma Ltd ADR share price volatility

Over the last 12 months, Can Fite Biopharma Ltd ADR's shares have ranged in value from as little as $0.74 up to $2.6. A popular way to gauge a stock's volatility is its "beta".

CANF.US volatility(beta: 1.59)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Can Fite Biopharma Ltd ADR's is 1.5949. This would suggest that Can Fite Biopharma Ltd ADR's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Can Fite Biopharma Ltd ADR overview

Can-Fite BioPharma Ltd. , a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical trial for the treatment of hepatocellular carcinoma, as well as in Phase IIb trial for the treatment of non-alcoholic steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, the company develops commercial predictive biomarker blood test kit for A3AR. Can-Fite BioPharma Ltd. has license and collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson; and collaboration agreement with Univo Pharmaceuticals to identify and co-develop specific formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases.

Frequently asked questions

What percentage of Can Fite Biopharma Ltd ADR is owned by institutions?
Currently 1.853% of Can Fite Biopharma Ltd ADR shares are held by institutions.
How many people work for Can Fite Biopharma Ltd ADR?
Latest data suggests 8 work at Can Fite Biopharma Ltd ADR.
When does the fiscal year end for Can Fite Biopharma Ltd ADR?
Can Fite Biopharma Ltd ADR's fiscal year ends in December.
Where is Can Fite Biopharma Ltd ADR based?
Can Fite Biopharma Ltd ADR's address is: 10 Bareket Street, Petah Tikva, Israel, 4951778
What is Can Fite Biopharma Ltd ADR's ISIN number?
Can Fite Biopharma Ltd ADR's international securities identification number is: US13471N2018
What is Can Fite Biopharma Ltd ADR's CUSIP number?
Can Fite Biopharma Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 13471N102

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site